Geneos Wealth Management’s iShares iBonds Dec 2024 Term Corporate ETF IBDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,584
Closed -$39.9K 2981
2024
Q3
$39.9K Hold
1,584
﹤0.01% 1280
2024
Q2
$39.8K Hold
1,584
﹤0.01% 1146
2024
Q1
$39.7K Hold
1,584
﹤0.01% 1148
2023
Q4
$39.5K Hold
1,584
﹤0.01% 1136
2023
Q3
$39.2K Hold
1,584
﹤0.01% 1148
2023
Q2
$39K Hold
1,584
﹤0.01% 1154
2023
Q1
$39K Hold
1,584
﹤0.01% 1145
2022
Q4
$38.7K Hold
1,584
﹤0.01% 1136
2022
Q3
$38K Sell
1,584
-1,000
-39% -$24.7K ﹤0.01% 1121
2022
Q2
$64K Sell
2,584
-300
-10% -$7.46K ﹤0.01% 1178
2022
Q1
$72K Hold
2,884
﹤0.01% 1217
2021
Q4
$74K Hold
2,884
﹤0.01% 1299
2021
Q3
$75K Buy
2,884
+1,584
+122% +$41.7K ﹤0.01% 1291
2021
Q2
$34K Hold
1,300
﹤0.01% 1659
2021
Q1
$34K Hold
1,300
﹤0.01% 1825
2020
Q4
$34K Hold
1,300
﹤0.01% 1654
2020
Q3
$34K Sell
1,300
-200
-13% -$5.29K ﹤0.01% 1419
2020
Q2
$39K Hold
1,500
﹤0.01% 1333
2020
Q1
$36K Hold
1,500
﹤0.01% 1251
2019
Q4
$38K Hold
1,500
﹤0.01% 1405
2019
Q3
$38K Hold
1,500
﹤0.01% 1318
2019
Q2
$38K Hold
1,500
﹤0.01% 1336
2019
Q1
$37K Sell
1,500
-430
-22% -$10.5K ﹤0.01% 1293
2018
Q4
$46K Sell
1,930
-600
-24% -$14.3K ﹤0.01% 1137
2018
Q3
$60K Buy
2,530
+430
+20% +$10.4K ﹤0.01% 1086
2018
Q2
$50K Sell
2,100
-430
-17% -$10.4K ﹤0.01% 1046
2018
Q1
$61K Buy
2,530
+2,100
+488% +$51.6K 0.01% 924
2017
Q4
$10K Hold
430
﹤0.01% 1649
2017
Q3
$10K Hold
430
﹤0.01% 1592
2017
Q2
$10K Hold
430
﹤0.01% 1554
2017
Q1
$10K Hold
430
﹤0.01% 1498
2016
Q4
$10K Hold
430
﹤0.01% 1442
2016
Q3
$11K Hold
430
﹤0.01% 1349
2016
Q2
$10K Buy
+430
New +$10.8K ﹤0.01% 1341

Other funds holding IBDP

Geneos Wealth Management's IBDP Position: Q4 2024 in Review

Geneos Wealth Management sold out of iShares iBonds Dec 2024 Term Corporate ETF (IBDP) in Q4 2024, closing a stake of 1,584 shares — an estimated $39.9K sold.

Geneos Wealth Management first reported a position in IBDP in Q2 2016 and held it in 34 quarters. The position peaked at $75K in Q3 2021. 2 funds tracked by Wall St. Rank hold IBDP as of Q4 2024.

  • Geneos Wealth Management reported no remaining iShares iBonds Dec 2024 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 1,584 iShares iBonds Dec 2024 Term Corporate ETF shares in Q4 2024, an estimated $39.9K.
  • Geneos Wealth Management first reported a position in iShares iBonds Dec 2024 Term Corporate ETF in Q2 2016 and held it in 34 quarters.
  • Geneos Wealth Management's iShares iBonds Dec 2024 Term Corporate ETF position peaked at $75K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Corporate ETF as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.